Ozempic and other GLP-1 RAs could slow progression of some cancers, data suggest

Credit: Unsplash/CC0 Public Domain

Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *